KR101790250B1 - Soap composition comprising of medicinal plants - Google Patents
Soap composition comprising of medicinal plants Download PDFInfo
- Publication number
- KR101790250B1 KR101790250B1 KR1020160056380A KR20160056380A KR101790250B1 KR 101790250 B1 KR101790250 B1 KR 101790250B1 KR 1020160056380 A KR1020160056380 A KR 1020160056380A KR 20160056380 A KR20160056380 A KR 20160056380A KR 101790250 B1 KR101790250 B1 KR 101790250B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- soap
- present
- soap composition
- composition
- Prior art date
Links
- 239000000344 soap Substances 0.000 title claims abstract description 133
- 239000000203 mixture Substances 0.000 title claims abstract description 126
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 22
- 206010000496 acne Diseases 0.000 claims abstract description 22
- 241000186427 Cutibacterium acnes Species 0.000 claims abstract description 15
- 241000191963 Staphylococcus epidermidis Species 0.000 claims abstract description 12
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 12
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 11
- 230000000845 anti-microbial effect Effects 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 23
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 18
- 239000011734 sodium Substances 0.000 claims description 18
- 229910052708 sodium Inorganic materials 0.000 claims description 18
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000004088 foaming agent Substances 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 10
- 230000003020 moisturizing effect Effects 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000007844 bleaching agent Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000000284 extract Substances 0.000 abstract description 114
- 239000000419 plant extract Substances 0.000 abstract description 45
- 230000000694 effects Effects 0.000 abstract description 17
- 239000004480 active ingredient Substances 0.000 abstract description 7
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 229940055019 propionibacterium acne Drugs 0.000 abstract description 7
- 244000207667 Rumex vesicarius Species 0.000 abstract description 6
- 244000173853 Sanguisorba officinalis Species 0.000 abstract description 6
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract description 6
- 235000021501 Rumex crispus Nutrition 0.000 abstract description 5
- 241000267040 Sasa borealis Species 0.000 abstract description 5
- 206010012438 Dermatitis atopic Diseases 0.000 abstract description 4
- 241000193996 Streptococcus pyogenes Species 0.000 abstract description 4
- 201000008937 atopic dermatitis Diseases 0.000 abstract description 4
- 208000020154 Acnes Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000018927 edible plant Nutrition 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 53
- 244000075850 Avena orientalis Species 0.000 description 35
- 235000007319 Avena orientalis Nutrition 0.000 description 35
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 31
- 240000005499 Sasa Species 0.000 description 24
- 241000894006 Bacteria Species 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 241000196324 Embryophyta Species 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 12
- 238000000605 extraction Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 235000007558 Avena sp Nutrition 0.000 description 8
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 8
- -1 body wash Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 7
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 7
- 239000010478 argan oil Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 229920002674 hyaluronan Polymers 0.000 description 7
- 229960003160 hyaluronic acid Drugs 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 6
- 235000017491 Bambusa tulda Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000005639 Lauric acid Substances 0.000 description 6
- 244000082204 Phyllostachys viridis Species 0.000 description 6
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000011425 bamboo Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 108700004121 sarkosyl Proteins 0.000 description 6
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 6
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 6
- 206010003645 Atopy Diseases 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 235000002020 sage Nutrition 0.000 description 5
- 229940112950 sage extract Drugs 0.000 description 5
- 235000020752 sage extract Nutrition 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 240000003291 Armoracia rusticana Species 0.000 description 4
- 235000011330 Armoracia rusticana Nutrition 0.000 description 4
- 240000008067 Cucumis sativus Species 0.000 description 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 244000024873 Mentha crispa Species 0.000 description 4
- 235000014749 Mentha crispa Nutrition 0.000 description 4
- 241000366596 Osiris Species 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 4
- 241001135917 Vitellaria paradoxa Species 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229940119485 safflower extract Drugs 0.000 description 4
- 229940057910 shea butter Drugs 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 229940095696 soap product Drugs 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 240000005109 Cryptomeria japonica Species 0.000 description 2
- 235000009075 Cucumis anguria Nutrition 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 241001098054 Pollachius pollachius Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000003350 kerosene Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 2
- 229940082004 sodium laurate Drugs 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000273256 Phragmites communis Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000061184 Phyllobacteriaceae bacterium Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 235000015422 Rumex crispus ssp. crispus Nutrition 0.000 description 1
- 235000015426 Rumex crispus ssp. fauriei Nutrition 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229930185278 anthraglycoside Natural products 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical class C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940082009 galactoarabinan Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/22—Organic compounds, e.g. vitamins
- C11D9/38—Products in which the composition is not well defined
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C11D11/0011—
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D11/00—Special methods for preparing compositions containing mixtures of detergents
- C11D11/0082—Special methods for preparing compositions containing mixtures of detergents one or more of the detergent ingredients being in a liquefied state, e.g. slurry, paste or melt, and the process resulting in solid detergent particles such as granules, powders or beads
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D11/00—Special methods for preparing compositions containing mixtures of detergents
- C11D11/0094—Process for making liquid detergent compositions, e.g. slurries, pastes or gels
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/382—Vegetable products, e.g. soya meal, wood flour, sawdust
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/44—Perfumes; Colouring materials; Brightening agents ; Bleaching agents
- C11D9/442—Perfumes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/44—Perfumes; Colouring materials; Brightening agents ; Bleaching agents
- C11D9/444—Dyes; Pigments
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/44—Perfumes; Colouring materials; Brightening agents ; Bleaching agents
- C11D9/446—Bleaching agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
본 발명은 약용식물 추출물을 함유하는 비누 조성물에 관한 것으로, 더욱 자세하게는 유효성분으로서 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물을 포함을 포함하여 항염 활성 및 항균 활성을 갖는 비누 조성물에 관한 것이다.The present invention relates to a soap composition containing a medicinal plant extract, and more particularly to a soap composition having an anti-inflammatory activity and an antimicrobial activity, including a safflower extract, an oat extract and a sage extract as effective ingredients.
각종 산업시설이나 자동차 등에서 발생되는 배기가스의 영향으로 대기 오염 및 수질 오염 등의 공해문제가 심각해지고 있으며, 주거환경이 개선됨에 따라 거주공간의 난방효율이 현저하게 향상되어 피부가 건조한 상태로 유지되면서 피부가 거칠어지거나 조기에 노화되는 현상이 발생하고 있다.Pollution problems such as air pollution and water pollution are becoming serious due to the influence of exhaust gas generated in various industrial facilities and automobiles. As the living environment is improved, the heating efficiency of the living space is remarkably improved and the skin is kept dry The skin becomes rough or prematurely aged.
일반적으로 피부는 표면에서부터 표피, 진피, 피하조직으로 구성되는데, 표피의 가장 바깥쪽에는 피부의 표피세포가 노화되면서 생겨나는 각질층이 형성된다.In general, the skin consists of the epidermis, the dermis, and the subcutaneous tissue from the surface. On the outermost side of the epidermis, a stratum corneum is formed by aging of epidermal cells of the skin.
이러한 사람의 피부는 체내의 생리작용에 의한 노폐물을 체외로 배출시키는 기능과 인체에 필요한 산소공급을 위한 피부호흡의 기능을 가진다.The skin of such a person has the function of discharging the waste material due to the physiological action in the body to the outside of the body and the function of skin respiration for supplying oxygen necessary for the human body.
신체에서 분비되는 각종 노폐물이나 피지 등이 피부에 분포되어진 모공이나 피지선 등을 막게 되면, 노폐물 등이 피부의 상피조직 내에 축척되어 피부상피세포의 비정상적인 각화현상을 초래한다. 또한, 공기 중의 유해한 미생물이 피부표면에 흡착되면서 모공이나 땀구멍 등을 통해 피부 표면에 미생물 등이 침투하게 되면, 이는 바로 피부염증을 일으키게 되는 원인이 되고, 궁극적으로는 피부에 손상을 가져오게 되어 피부미용을 해치게 된다.When various wastes or sebum secreted from the body are blocked in pores or sebaceous glands distributed in the skin, wastes etc. are accumulated in the epithelium of the skin, resulting in abnormal keratinization of the skin epithelium. In addition, when harmful microorganisms in the air are adsorbed on the surface of the skin, microorganisms penetrate through the pores or pores to the surface of the skin, which causes skin inflammation, and ultimately damages the skin Beauty is harmed.
따라서 사람의 피부는 항상 인체의 생리작용과 조화를 이룰 수 있도록 깨끗하게 유지시켜 주고 관리해야 하며, 이러한 과정이 선결되면 건강하고 탄력 있는 피부를 유지할 수 있게 된다.Therefore, human skin should always be kept clean and maintained in order to harmonize with physiological function of human body, and when this process is established, healthy and elastic skin can be maintained.
이와 같이, 피부를 청결하게 세척시키고 보호시켜 주기 위한 구체적인 방법 중의 하나가 비누의 사용이다.Thus, one of the specific methods for cleansing and protecting the skin is the use of soap.
일반적으로 비누는 세수 및 세안이나 목욕과정에서 신체의 각질, 노폐물 및 때와 같은 이물질을 제거하기 위해 사용하는 세정제로, 용도에 따라서 세안 및 목욕을 위한 세안용 비누와 옷감 등의 빨래를 위한 세탁용 비누로 크게 나눌 수 있다. 비누에서 기본적으로 요구되는 효능은 우수한 세정력이다. 하지만, 생활이 풍요로워지면서 건강에 대한 관심이 고조됨에 따라, 세정력 이외의 다른 효능에 대한 요구가 증대되고 있다.In general, soap is a detergent used to remove foreign substances such as body wash, kerosene, and so on during washing and bathing. It is used for washing soap and cloth for cleansing and bathing It can be divided into soap. The essential efficacy in soap is excellent detergency. However, as life becomes more abundant and interest in health is heightened, demands for efficacy other than detergency are increasing.
상기 세안용 비누는 주로 식물성유지와 계면활성제가 주성분을 이루고 있으며 이들 성분을 기본으로 하여 각각의 기능성 물질을 첨가하여 다양한 종류의 세안용 비누를 만들게 된다. 즉, 첨가한 기능성 물질에 따라서, 인삼을 함유한 인삼비누, 우유를 함유한 우유비누, 쑥을 함유한 쑥비누, 오이를 함유한 오이비누, 미세한 맥반석 분말을 함유한 맥반석비누 등으로 그 종류는 헤아릴 수 없을 정도로 많다.The cleansing soap consists mainly of vegetable oils and surfactants. Based on these ingredients, various functional substances are added to make various kinds of cleansing soap. That is, depending on the added functional material, ginseng soap containing ginseng, milk soap containing milk, mugwort soap containing mugwort, cucumber soap containing cucumber, and elvan soap containing fine kerosene powder can be categorized into There are so many that can not be counted.
이러한 비누는 물과 접촉하는 과정에서 쉽게 분해되면서 계면(界面)에 잘 달라붙어 계면의 표면장력을 저하시킴으로써 노폐물이나 때 등을 계면으로부터 분리시켜 세정작용을 수행하게 된다.Such a soap is easily decomposed in the process of contacting with water and adheres well to the interface so that the surface tension of the interface is lowered, thereby separating the waste matter and the like from the interface to perform the cleaning action.
그런데, 사람의 피부는 피지선에서 피지가 모공을 통하여 피부표면으로 수분 증발을 억제하며 피부의 탄력을 유지하고 있으나, 피부 상피세포의 비정상적인 각화에 의하여 모공이 막히고 피지가 피부표면으로 배출되지 않으면 피지가 모공 내에 뭉쳐있게 되고, 여기에 혐기성 균주가 침투하게 되면 염증이 생겨 여드름 등 각종 피부질환이 발생하게 된다. 또한, 피부 표면으로부터 피지가 잘 배출되더라도 세정 후 시간이 흐르면 공기 중의 미생물들이 피부 표면에 번식하여 피지를 노출시킴으로써 피부의 표면을 악화시킨다.However, the skin of the human skin is suppressed from evaporation to the skin surface through the pores of the sebaceous gland, and the elasticity of the skin is maintained. However, if the pore is blocked by the abnormal keratinization of the skin epithelium, When the anaerobic strain penetrates into the pores, inflammation occurs and various skin diseases such as acne are caused. In addition, even if the sebum is well discharged from the surface of the skin, if the time passes after the cleaning, microorganisms in the air propagate on the surface of the skin to expose the sebum, thereby deteriorating the surface of the skin.
이런 문제점을 해결하기 위하여, 건강을 증진시키기 위한 각종 효능이 부가된 기능성 비누를 개발하기 위한 노력이 끊임없이 진행되고 있다.In order to solve such a problem, efforts to develop a functional soap having various effects for improving health have been continuously carried out.
이에, 본 발명자는 여드름 유발 원인균 및 호기성 피부 상재균에 우수한 항균성을 갖는 천연 소재로서 비누에 적용할 수 있는 약용식물을 찾고자 연구한 결과, 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물을 특정 배합비로 포함하는 비누 조성물이 항염 활성을 가지고, 또한, 여드름 유발균인 프로피오니박테리움 아크네스(Propionibacterium acnes) 및 피부상재균에 해당하는 황색포도상구균(Staphylococcus aureus), 표피포도구균(Staphylococcus epidermidis) 및 화농성 연쇄상구균(Sreptococcus pyogenes)에 대한 강한 항균 활성을 보이는 것을 확인함으로써 본 발명을 완성하였다.Accordingly, the present inventor has searched for a medicinal plant which can be applied to soap as a natural material having excellent antimicrobial activity against acne-inducing bacteria and aerobic skin-bearing bacteria, and found that the medicinal plants which can be applied to soap include a spear extract, an oat extract and a Sasa extract The soap composition has anti-inflammatory activity and is also effective against acne-causing bacteria such as Propionibacterium acnes and Staphylococcus aureus , Staphylococcus epidermidis , and purulent streptococcus, ( Sreptococcus pyogenes ), and thus the present invention has been completed.
따라서 본 발명의 목적은 천연 약용식물 추출물을 이용하여 장기간 사용에도 인체에 안정하면서 여드름 유발 원인균 및 피부상재균에 대한 항균 활성이 우수한 비누 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a soap composition which is stable to human body and has excellent antimicrobial activity against acne-inducing bacteria and skin topical bacteria even when used for a long time by using natural medicinal plant extracts.
상기와 같은 본 발명의 목적을 달성하기 위해서, In order to achieve the above-mentioned object of the present invention,
본 발명은 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물로 이루어진 군으로부터 선택된 1종 이상의 추출물을 포함하는 비누 조성물을 제공한다.The present invention provides a soap composition comprising one or more extracts selected from the group consisting of Asteraceae Extract, Oat Extract, and Sasa Extract.
본 발명의 일실시예에 있어서, 상기 조성물은 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물을 모두 포함할 수 있다.In one embodiment of the present invention, the composition may include all or part of an extract of Alaska pollack, an extract of Osiris, and a sage extract.
본 발명의 일실시예에 있어서, 상기 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물은 1 : 2 : 2의 중량비로 포함될 수 있다.In one embodiment of the present invention, the extracts of Rhododendron syrup extract, oat extract and Sasa extract may be contained at a weight ratio of 1: 2: 2.
본 발명의 일실시예에 있어서, 상기 추출물은 전체 비누 조성물 100중량부를 기준으로 1 내지 10중량부로 포함될 수 있다.In one embodiment of the present invention, the extract may be contained in an amount of 1 to 10 parts by weight based on 100 parts by weight of the total soap composition.
본 발명의 일실시예에 있어서, 상기 조성물은 비누칩, 기포제, 천연지방산, 보습제, 나트륨셀룰로오스, 염화나트륨, 색소, 향료, 표백제, 방부제, 항산화제, 변색방지제 및 정제수로 이루어진 군으로부터 선택된 1종 이상을 더 포함할 수 있다.In one embodiment of the present invention, the composition is at least one selected from the group consisting of a soap chip, a foaming agent, a natural fatty acid, a moisturizer, sodium cellulose, sodium chloride, a pigment, a flavoring agent, a bleaching agent, an antiseptic agent, As shown in FIG.
본 발명의 일실시예에 있어서, 상기 조성물을 액상, 크림상, 페이스트상 또는 고체상의 제형을 가질 수 있다.In one embodiment of the present invention, the composition may have a liquid, cream, paste or solid form.
본 발명의 일실시예에 있어서, 상기 조성물은 항염 활성 및 항균 활성을 가질 수 있다.In one embodiment of the present invention, the composition may have anti-inflammatory activity and antibacterial activity.
본 발명의 일실시예에 있어서, 상기 항균 활성은 여드름 유발균 및 호기성 피부상재균에 대한 항균 활성일 수 있다.In one embodiment of the present invention, the antimicrobial activity may be an antimicrobial activity against acne-causing bacteria and aerobic skin-bearing bacteria.
본 발명의 일실시예에 있어서, 상기 여드름 유발균은 프로피오니박테리움 아크네스(P. acnes)일 수 있다.In one embodiment of the present invention, the acne-causing bacterium may be P. bacterium acnes.
본 발명의 일실시예에 있어서, 상기 호기성 피부상재균은 황색포도상구균(Staphylococcus aureus), 표피포도구균(Staphylococcus epidermidis) 또는 화농성 연쇄상구균(Sreptococcus pyogenes)일 수 있다.In one embodiment of the present invention, the aerobic dermatophytes may be Staphylococcus aureus , Staphylococcus epidermidis , or Sreptococcus pyogenes .
본 발명에 따른 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물을 포함하는 비누 조성물은 항염 활성을 가지며, 또한, 여드름 유발균인 프로피오니박테리움 아크네스(Propionibacterium acnes) 및 피부상재균에 해당하는 황색포도상구균(Staphylococcus aureus), 표피포도구균(Staphylococcus epidermidis) 및 화농성 연쇄상구균(Sreptococcus pyogenes)에 대한 강한 항균 활성을 갖는바, 여드름 피부 및 아토피성 피부염 개선에 효과를 갖는 새로운 기능성 비누 조성물로서 유용하게 사용될 수 있다. 특히 소리쟁이, 오이풀 및 조릿대는 식용 가능한 식물로서 이로부터 유래한 추출물을 포함하는 본 발명의 비누 조성물은 장기간 사용에도 안전한 이점을 가진다.The present invention relates to a soap composition comprising a safflower extract, an oat extract and a Sasa extract, which has an anti-inflammatory activity and is also effective against acne-causing bacteria such as Propionibacterium acnes and Staphylococcus aureus It has a strong antimicrobial activity against Staphylococcus aureus , Staphylococcus epidermidis and Sreptococcus pyogenes and can be effectively used as a novel functional soap composition having an effect for improving acne skin and atopic dermatitis . In particular, the soap compositions of the present invention comprising extracts derived therefrom, which are edible plants, have a safety advantage over long-term use.
도 1은 마우스 대식세포(RAW264.7 세포)에 본 발명의 소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 및 이들의 혼합물의 각각 적용에 따른 산화질소(NO) 생성 억제 정도를 그래프로 나타낸 것이다(Cont: LPS 및 추출물을 처리하지 않은 무처리군, 200: 본 발명의 추출물을 200μg/ml로 처리한 후 LPS를 처리하지 않은 실험군).
도 2a 내지 2c는 본 발명의 약용식물 추출액(분말화하기 전 단계)을 나타낸 사진이다.
도 3은 본 발명의 비누 조성물을 이용하여 생산된 비누 제품을 나타낸 사진이다.FIG. 1 is a graph showing inhibition of nitric oxide (NO) production according to the application of the present invention to the mouse macrophages (RAW264.7 cells) according to the application of the present invention, oat extract, sasa extract and mixtures thereof (Cont: 200: the experimental group treated with 200 μg / ml of the extract of the present invention and not treated with LPS).
2A to 2C are photographs showing the medicinal plant extract (before powdering) of the present invention.
3 is a photograph showing a soap product produced using the soap composition of the present invention.
본 발명은 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물로 이루어진 군으로부터 선택된 1종 이상의 추출물을 포함하는 비누 조성물을 제공함에 그 특징이 있다.The present invention is characterized by providing a soap composition comprising at least one extract selected from the group consisting of a safflower extract, an oat extract, and a sage extract.
본 명세서에서 언급하는 ‘소리쟁이’는 학명이 Rumex crispus L.이며 여러 해살이 풀로, 양제근, 송구지, 야당귀 등으로 불리며 전국의 들판과 산비탈의 습한 곳에서 흔하게 자란다.땅속에 비대한 뿌리줄기를 가지고 있으며, 굵은 줄기는 곧게 서서 30-80cm 정도로 자라는데, 세로 줄이 많으며 녹색바탕에 자주빛이 돈다. 어린 잎이 자라나올 무렵에는 키가 작고 나지막해 보인다. 봄에 어린 순을 나물로 먹고 뿌리는 약으로 쓴다. 이와 같은 소루쟁이에는 아스코르빈산, 크리소파놀, 에모딘, 안트라키논 유도체, 싱아산칼슘, 정유, 옥시메탈 안트로키논, 크리소판산, 안트라글리코시드 등이 있다."Curly dock" referred to herein is the scientific name Rumex crispus L. It is called "Yangjingun", "Songgui", "opposition ear" etc. It grows frequently in the wet areas of the fields and mountain slopes of the country. It has bloomed roots in the ground and the thick stem grows up to 30-80cm There are many vertical lines, and the backlight turns on the green background. By the time the young leaves grow up, they look tall and tiny. In spring, young seeds are eaten as herbs and rooted as medicine. Examples of such molluscs include ascorbic acid, crysopanol, emodin, anthraquinone derivatives, calcium monacalcium, essential oils, oxymetalanthroquinone, chrysopanic acid, anthraglycoside and the like.
본 명세서에서 언급하는 ‘오이풀’은 학명이 Sanguisorba officinalis L.이며 쌍떡잎식물 이판화군 장미목 장미과의 여러해살이풀로 산이나 들에서 자란다. 굵은 뿌리줄기에서 갈라진 뿌리는 양끝이 뵤족한 원기둥 모양으로 굵어지고, 원대는 곧게 1m 정도 자라며, 위에서 가지가 갈라진다. 잎은 어긋나고 깃꼴 겹잎이며, 뿌리잎은 작은잎이 7 ∼ 11개이고, 잎자루와 작은잎자루가 있다. 작은잎은 긴 타원형이며, 가장자리에 톱니가 있고, 줄기잎은 작아지며 대가 없어진다. 꽃은 7 ∼ 9월에 피고 검붉은색이며, 수상꽃차례에 달린다. 꽃이삭은 타원형 또는 거꾸로 선 달걀 모양의 타원형이며, 위에서부터 꽃이 피기 시작한다. 꽃받침조각과 수술은 4개씩이고 꽃잎이 없으며 꽃밥은 흑갈색이다. 열매는 수과로 10월에 익고 사각형이며 꽃받침으로 싸여 있다. 종류는 오이풀, 가는오이풀, 긴오이풀, 큰오이풀, 산오이풀, 자주가는오이풀, 술오이풀, 두메오이풀, 구슬오이풀, 구름오이풀이 있다. 또한, 한방에서 뿌리를 지유(地楡)라고 하며, 수렴, 해열, 설사, 이질, 지혈, 월경과다, 객혈 및 화상과 열상 등에 사용하는데, 17%의 타닌과 사포닌이 함유되어 있다. 한국, 중국, 동부 시베리아, 일본 및 캄차카 등지에 분포한다."Sanguisorba officinalis' scientific names mentioned herein are the Sanguisorba officinalis L. is a perennial plant of Rosaceae Rosaceae which grows in mountains or fields. The roots in the coarse rootstock are thickened in a cylindrical shape with rounded ends at both ends. Leaves are alternate phyllotaxis, and the root leaves are 7 ~ 11 small leaves, with petiole and small petiole. The small leaf is long oval, the edge has sawtooth, the stem leaf becomes smaller and the stem disappears. Flowers bloom from July to September and are reddish in color, and run on water inflorescence. Flower ears are elliptical or inverted ovate elliptical and begin to bloom from the top. There are four calyxes and stamens, no petals, and anthers are dark brown. The fruit is achene, ripened in October, square, and covered with calyx. There are various types of oat, oat, long oat, big oat, mountain oat, common oat, sour oat, dume oak, bead oat, and cloud oat. In addition, the roots are called zyu (root) in one room, and they are used for convergence, fever, diarrhea, dysentery, hemostasis, excessive menstruation, hemoptysis, burns and burns and contain 17% of tannins and saponins. It is distributed in Korea, China, Eastern Siberia, Japan and Kamchatka.
본 명세서에서 언급하는 ‘조릿대’는 학명이 Sasa borealis(Hack.) Makino.이며 대나무 중에서 가장 작은 대나무로서 우리나라 중부 이남 지방의 산에 빽빽하게 무리 지어 흔히 자란다. 조릿대는 동의보감, 본초강목, 신농본초경에 따르면 인삼을 훨씬 능가한다고 할 만큼 놀라운 약성을 지닌 약초이며, 대나무 중에서 약성이 제일 강하여 조릿대 한 가지만 써도 당뇨병, 고혈압, 위궤양 등의 난치병이 완치된 경우가 적지 않다고 한다. 또한, 조릿대는 열을 내리고 독을 풀며, 가래를 없애고 소변을 잘 나오게 하며, 암세포를 억제하는 등의 효과가 있다고 보고되고 있다. Sasa borealis (Hack.) Makino . Is the smallest bamboo of the bamboo. It is a small bamboo, and it grows thickly in the mountains of the southern part of Korea. Sasa bamboo is an herb with remarkable potency that far exceeds that of ginseng according to Dongbokbo, Bonchochangmok, and Goddess Maternal. It is rare that bamboo is the most resistant to the disease, and the intractable diseases such as diabetes, hypertension and gastric ulcer are completely cured do. In addition, Sasa bamboo has been reported to reduce fever, remove poison, eliminate sputum, urinate well, inhibit cancer cells, and the like.
본 발명자는 우수한 항염증 활성 및 항균성을 갖는 천연 소재로서 비누에 적용할 수 있는 약용식물을 찾고자 연구하였으며, 그 결과 소리쟁이 추출물, 오이풀 추출물 또는/및 조릿대 추출물을 포함하는 비누 조성물이 여드름 유발 원인균(프로피오니박테리움 아크네스) 및 호기성 피부 상재균(황색포도상구균, 표피포도구균 및 화농성 연쇄상구균)에 대한 강한 항균 활성을 보이는 것을 최초로 규명하였다.The present inventor has searched for a medicinal plant which can be applied to soap as a natural material having excellent anti-inflammatory activity and antimicrobial activity. As a result, it has been found that a soap composition comprising a safflower extract, an oat extract and / or a Sasa extract, Propionibacterium acnes) and aerobic skin topical bacteria (Staphylococcus aureus, Staphylococcus epidermidis and purulent streptococcus).
그러므로 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물로 이루어진 군으로부터 선택된 1종 이상의 추출물을 유효성분으로 포함하는 본 발명의 조성물은 피부에 적용하는 조성물 소재로서 유용하게 사용될 수 있다. Therefore, the composition of the present invention, which comprises at least one extract selected from the group consisting of Asteraceae extract, Osiris extract and Sasa extract, can be effectively used as a composition for skin application.
본 발명에 따른 추출물은 당업계에 공지된 추출 및 분리하는 방법을 사용하여 천연으로부터 추출 및 분리하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된‘추출물’은 적절한 용매를 이용하여 약용식물(소리쟁이, 오이풀, 조릿대) 로부터 추출한 것이며, 예를 들어, 상기 약용식물의 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다.The extract according to the present invention can be obtained by extracting and isolating from nature using an extraction and separation method known in the art, and the 'extract' defined in the present invention can be obtained from a medicinal plant For example, a crude extract, a polar solvent-soluble extract or a non-polar solvent-soluble extract of the medicinal plant.
상기 약용식물(소리쟁이, 오이풀, 조릿대)로부터 추출물을 추출하기 위한 적절한 용매로는 약학적으로 허용되는 유기용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있으며, 이에 제한되지는 않으나, 예를 들어, 정제수(물), 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있다. 바람직하게는 물 또는 에탄올을 사용하는 것이 좋다.As an appropriate solvent for extracting the extract from the medicinal plants (spearmint, oat, saddle), any pharmaceutically acceptable organic solvent may be used, and water or an organic solvent may be used, including, but not limited to, For example, alcohols having 1 to 4 carbon atoms, such as purified water (water), methanol, ethanol, propanol, isopropanol, butanol, acetone, Various solvents such as ether, benzene, chloroform, ethyl acetate, methylene chloride, hexane and cyclohexane may be used alone or in combination . Preferably, water or ethanol is used.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 약용식물 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.As the extraction method, any one of the methods such as hot water extraction method, cold extraction method, reflux cooling extraction method, solvent extraction method, steam distillation method, ultrasonic extraction method, elution method and compression method can be selected and used. In addition, the desired extract may be further subjected to a conventional fractionation process or may be purified using a conventional purification method. The method for producing the medicinal plant extract of the present invention is not limited, and any known method can be used.
예를 들면, 본 발명의 조성물에 포함되는 약용식물(소리쟁이, 오이풀, 조릿대)은 상기한 열수 추출 또는 용매 추출법으로 추출된 1차 추출물을, 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography) 등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다.For example, the medicinal plants (spearmint, oat, and sage) contained in the composition of the present invention may be prepared by subjecting the primary extract extracted by the hot water extraction or solvent extraction method described above to an additional process such as vacuum distillation, freeze drying, And can be produced in a powder state. Further, the primary extract can be further purified by using various chromatographies such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography and the like, You can get it.
따라서 본 발명에 있어서 약용식물(소리쟁이, 오이풀, 조릿대)은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, the medicinal plants (spruce, oat, and sage) in the present invention include all extracts, fractions, and purified products obtained in each step of extraction, fractionation, or purification, and diluted solutions, concentrates, or dried products thereof.
본 발명에서 세 가지 약제들(소리쟁이, 오이풀, 조릿대)은 모두를 한꺼번에 넣고 추출할 수도 있고 각각 추출한 후 혼합하여 사용할 수도 있으나, 유효성분의 효율적 추출과, 약용식물의 혼합 추출 시 부성분의 추출을 최대한 억제하기 위하여 개별 추출 후 혼합 사용하는 것이 바람직하다.In the present invention, all of the three medicaments (Spruce, Oasi, Sasae) may be put together and extracted, or they may be separately mixed and used. However, efficient extraction of the active ingredient and extraction of the subcomponents during mixed extraction of medicinal plants It is preferable to use them separately and then mix them together.
본 발명의 일실시예에 따른 약용식물(소리쟁이, 오이풀, 조릿대) 추출물을 제조하는 방법을 조금 더 구체적으로 살펴보면 다음과 같다.The method for preparing the medicinal plants (spearmint, oat, and sage) extract according to an embodiment of the present invention will be described in more detail as follows.
소리쟁이, 오이풀, 조릿대 각각에 중량 대비 5-10배의 물을 첨가하여 50-60℃ 온도에서 끊여 수용액 양이 1/3이 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물을 처음 용량으로 첨가한 후 50-60℃ 온도에서 수용액 양이 1/3이 될 때까지 끊여 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물 각각을 2차 수득하였다. 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 여과한 뒤 농축 및 동결건조 과정을 거쳐 최종적으로 본 발명의 소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 각각을 파우더 형태로 제조하였다.5-10 times of weight of water was added to each of the shiitake, oacule and bupropar at a temperature of 50-60 ° C. When the amount of the aqueous solution became 1/3, the extract solution except for the shredded was firstly obtained, After the addition at the initial dose, the mixture was terminated at a temperature of 50-60 ° C until the amount of the aqueous solution became 1/3, to thereby obtain a second extract of Cryptomeria japonica extract, Oatmeal extract and Sasa extract. The first extract and the second extract thus obtained were combined, filtered, concentrated and lyophilized, and finally, each of the extracts of Saury, Oat and Sasa extract of the present invention was prepared in powder form.
건조된 세 가지 약용식물(소리쟁이, 오이풀, 조릿대)은 모두를 한꺼번에 넣고 추출할 수도 있고 각각 추출한 후 혼합하여 사용할 수도 있으나 유효성분의 효율적 추출과, 약용식물의 혼합 추출 시 부성분의 추출을 최대한 억제하기 위하여 개별 추출 후 혼합 사용법을 따랐다.The three dried medicinal plants (Phragmites, Oasi, Sasae) can be extracted all at once, or they can be mixed after they are extracted. However, efficient extraction of active ingredients and extraction of subcomponents during mixed extraction of medicinal plants are minimized To do this, individual extraction and mixing methods were followed.
본 발명의 상기 소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 및 이들의 혼합물은 우수한 항염증 활성을 가진다. 또한, 상기 추출물을 이용하여 제조한 비누 조성물의 경우 여드름 유발 원인균(프로피오니박테리움 아크네스) 및 피부상재균에 해당하는 황색포도상구균(Staphylococcus aureus), 표피포도구균(Staphylococcus epidermidis) 및 화농성 연쇄상구균(Sreptococcus pyogenes)에 대한 강한 항균 활성을 보인다.The extracts of the present invention, oat extract, sasa extract and mixtures thereof have excellent anti-inflammatory activity. In addition, in the case of the soap composition prepared using the above extract, Staphylococcus aureus , Staphylococcus epidermidis , and purulent streptococcus, which are causative agents of acne (Propionibacterium acnes) ( Sreptococcus pyogenes ).
본 발명의 일실시예에 있어서, 상기 조성물은 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물을 1-2 : 1-2 : 1-2의 중량비로 포함할 수 있으며, 바람직하게는 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물을 1 : 2 : 2의 중량비로 포함할 수 있다.In one embodiment of the present invention, the composition may contain a mixture of Alaska pollack extract, oat extract and Sasa extract at a weight ratio of 1-2: 1-2: 1-2, And Sasa extract in a weight ratio of 1: 2: 2.
따라서 본 발명의 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물로 이루어진 군으로부터 선택된 1종 이상의 추출물을 포함하는 조성물은 본 발명의 조성물은 피부염증 및 여드름 예방/개선/치료 효과를 가진 기능성 비누 조성물로서 유용하게 사용될 수 있다.Therefore, the composition of the present invention comprising at least one extract selected from the group consisting of the extracts of Rhododendron japonica extract, oat extract and Sasa extract is useful as a functional soap composition having skin inflammation and acne prevention / improvement / therapeutic effect Can be used.
본 발명의 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물은 비누 조성물 총 중량에 대하여 0.01 내지 10.0중량%로 포함될 수 있으며, 조성물에 1μg/ml 내지 10000μg/ml의 농도로 포함될 수 있다.The composition of the present invention may contain 0.01 to 10.0% by weight based on the total weight of the soap composition, and may be contained in the composition at a concentration of 1 μg / ml to 10000 μg / ml.
본 발명의 일실시예에 있어서, 상기 비누 조성물은 상기 유효성분 이외에 비누칩, 기포제, 천연지방산, 보습제, 나트륨셀룰로오스, 염화나트륨, 색소, 향료, 계면활성제, 표백제, 방부제, 항산화제, 변색방지제 및 정제수로 이루어진 군으로부터 선택된 1종 이상을 더 포함할 수 있다.In one embodiment of the present invention, the soap composition may contain, in addition to the active ingredient, a soap chip, a foaming agent, a natural fatty acid, a moisturizer, sodium cellulose, sodium chloride, a pigment, a flavoring, a surfactant, a bleaching agent, an antiseptic, And at least one member selected from the group consisting of
본 발명의 비누 조성물은 상기와 같은 유효성분(소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물)과 함께 비누베이스 조성물을 함유할 수 있다.The soap composition of the present invention may contain a soap base composition together with the above-mentioned active ingredients (rosemary extract, oat extract, sage extract).
본 명세서에서 언급하는 ‘비누베이스 조성물’은 비누의 기본을 형성하는 구성 물질로 이루어진 조성물로서, 일반적으로 당해 기술 분야에서 사용되는 비누의 구성성분을 포함할 수 있다.As used herein, a soap base composition is a composition of constituent materials that form the basis of a soap, and may generally comprise constituents of the soap used in the art.
상기 비누베이스 조성물은 비누칩, 기포제, 보습제, 염화나트륨, 색소, 향료, 표백제, 방부제, 항산화제, 변색방지제 및 정제수로 이루어진 군으로부터 선택된 1종 이상을 포함할 수 있다.The soap base composition may comprise at least one member selected from the group consisting of soap chips, foaming agents, moisturizing agents, sodium chloride, coloring matters, fragrances, bleaches, preservatives, antioxidants, discoloration inhibitors and purified water.
본 명세서에서 언급하는 ‘비누칩’이란 일반비누 제조 공정에서 사용하는 원료로 Soap Chip 또는 Soap Noodle라 불리며, 팜이나 코코넛오일이 바로 생산되는 현지(말레이지아나 필리핀 등)항구에 보통은 플랜트 공장을 지어서 비누라는 형태의 덩어리 칩을 생산하는데, 이러한 비누덩어리를 비누칩이라 한다.The term 'soap chip' as used herein refers to a soap chip or soap noodle used in a general soap manufacturing process and usually comprises a plant factory in a local (Malaysia or Philippines) port where a palm or coconut oil is immediately produced Soap clusters are called soap chips.
본 명세서에서 언급하는 ‘기포제(foaming agent)’란 안정인 거품을 형성시키기 위해, 용액 또는 원료에 첨가하는 물질로서 용액계의 기포제는 계면활성제의 일종이다. 그 예로는 소듐 라우레이트(sodium laurate), 소듐 코코일 이세티오네이트(sodium cocoyl isethionate), 소듐라우로일사르코시네이트(Sodium lauroyl sarcosinate), 사르코시아네이트(Sarcosinates), 포타슘라우레이트(Potassium laurate), 라우릭산(Lauric acid) 및 설포숙시네이트(sulfosuccinates), 글루탐산(glutamic acid) 등의 음이온 계면활성제; 코카미도 디에탄올아미드(Cocamido diethanolamide), 알킬 폴리글루코시드(alkyl polyglucoside), 폴리소르베이트 20(polysorbate20), PEG-100 스테아레이트(Stearate) 및 폴리소르베이트 60(Polysorbate 60) 등의 비이온 계면활성제; 및 코코아미도프로필 베타인(Cocoamidopropyl Betaine) 등의 양성계면활성제 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다. 한편, 본 발명의 일실시예에 있어서, 상기 기포제로 소듐코코일이세치오네이트(Sodium cocoyl isethionate), 소듐라우로일사르코시네이트(Sodium lauroyl sarcosinate) 및 포타슘라우레이트(Potassium laurate)를 혼합하여 사용할 수 있다.As used herein, the term " foaming agent " refers to a substance added to a solution or a raw material to form a stable foam, and a solution-type foaming agent is a kind of surfactant. Examples include sodium laurate, sodium cocoyl isethionate, sodium lauroyl sarcosinate, sarcosinates, potassium laurate, sodium laurate, Anionic surfactants such as lauric acid and sulfosuccinates, glutamic acid and the like; A nonionic surfactant such as Cocamido diethanolamide, alkyl polyglucoside,
본 명세서에서 언급하는 ‘천연지방산’이란 천연 유래의 지방산으로 기포제와 함께 사용하는 경우 미세하고 작은 기포가 풍부하게 발생될 수 있도록 하는 기포보조제 역할을 한다. 그 예로는, 미리스틱산(Myristic acid), 팔미틱산(Palmitic acid), 스테아릭산(Stearic acid), 라우릭산(Lauric acid) 등이 있으며, 통상의 기술자가 이를 적절하게 선택할 수 있다. 한편, 본 발명의 일실시예에 있어서, 상기 천연지방산으로는 라우릭산을 사용할 수 있으며, 기포제에 라우릭산의 혼합 사용하는 경우 미세한 작은 기포가 풍부하게 발생하여 피부 과지질, 각질, 화장 잔유물 등의 각종 노폐물과 흡착하는 능력이 커져 매우 효과적으로 제거할 수 있다.The 'natural fatty acid' referred to in the present specification is a naturally occurring fatty acid, and when used in combination with a foaming agent, serves as a foam assistant to enable fine and small bubbles to be abundantly generated. Examples thereof include Myristic acid, Palmitic acid, Stearic acid, Lauric acid and the like, and those skilled in the art can appropriately select them. Meanwhile, in one embodiment of the present invention, lauric acid may be used as the natural fatty acid, and when mixed with lauric acid as a foaming agent, minute small bubbles are abundantly generated, and skin, lipid, keratin, The ability to adsorb with various waste materials becomes large and can be removed very effectively.
본 명세서에서 언급하는 ‘보습제’란 피부의 수분 유지력을 높이는 성분으로 갈락토아라비난 (Galactoarabinan), 아르간 오일, 시어버터, 히아루론산, 글리세린 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다. 한편, 본 발명의 일실시예에 있어서, 상기 보습제로 시어버터, 아르간 오일, 소듐히알루론산 및 글리세린을 혼합하여 사용할 수 있다.The 'moisturizing agent' referred to in the present specification includes galactoarabinan, argan oil, shea butter, hyaluronic acid, glycerin and the like as a component for enhancing moisture retention of the skin, and a person skilled in the art can appropriately select it. Meanwhile, in one embodiment of the present invention, shea butter, argan oil, sodium hyaluronic acid and glycerin may be mixed with the moisturizing agent.
본 발명의 상기 비누베이스 조성물에 포함되는 구성성분으로서‘나트륨셀룰로오스’는 기포제에 함께 첨가 시에는 작은 기포의 유지 시간을 훨씬 길게 가져 갈 수 있어 피부에서 혼합 기포제의 유효 작용이 매우 높아지도록 하는 역할을 한다.The 'sodium cellulose' as a constituent component of the soap base composition of the present invention, when added together with the foaming agent, can lead to a much longer holding time of the small bubbles, thereby increasing the effective function of the mixing foam agent in the skin do.
본 발명의 상기 비누베이스 조성물에 포함되는 구성성분으로서 ‘염화나트륨’은 비누를 딱딱하게 만들기 위한 고형제의 역할을 한다.As a component of the soap base composition of the present invention, 'sodium chloride' serves as a solid agent for making the soap hard.
상기에서 언급한 유효성분 및 비누베이스를 포함하는 본 발명의 비누 조성물은 액상, 크림상, 페이스트상 또는 고체상의 제형일 수 있으나, 비누 조성물로 기능할 수 있는 것이면 어떠한 타입의 제형도 포함하는 개념이며 특별히 그 종류를 한정하는 것은 아니다.The soap composition of the present invention comprising the above-mentioned active ingredient and soap base may be in the form of a liquid, cream, paste, or solid form, but it is a concept including any type of formulation as long as it can function as a soap composition It does not particularly limit the kind thereof.
본 발명의 일실시예에 있어서, 약용식물 추출물로서 소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 및 이들의 혼합물 각각은 비누 조성물 총 100중량부를 기준으로 1-10중량부로 포함될 수 있으며; 비누칩은 비누 조성물 총 100중량부를 기준으로 하여 60-70중량부로 포함될 수 있고; 기포제는 비누 조성물 총 100중량부를 기준으로 1-30중량부로 포함될 수 있으며; 천연지방산은 비누 조성물 총 100중량부를 기준으로 1-20중량부로 포함될 수 있고; 보습제는 비누 조성물 총 100중량부를 기준으로 1-5중량부로 포함될 수 있으며; 나트륨셀룰로오스는 비누 조성물 총 100중량부를 기준으로 0.1-10중량부로 포함될 수 있고; 염화나트륨은 비누 조성물 총 100중량부를 기준으로 0.1-5중량부로 포함될 수 있다.In one embodiment of the present invention, the medicinal plant extract may contain 1-10 parts by weight of the horsetail extract, oat extract, bosom extract and mixtures thereof, based on 100 parts by weight of the total composition of the soap composition; The soap chips may be included in 60 to 70 parts by weight based on 100 parts by weight of the total of the soap composition; The foaming agent may be included in an amount of 1 to 30 parts by weight based on 100 parts by weight of the total amount of the soap composition; The natural fatty acid may be contained in an amount of 1-20 parts by weight based on 100 parts by weight of the total of the soap composition; The moisturizing agent may be included in an amount of 1 to 5 parts by weight based on 100 parts by weight of the total amount of the soap composition; The sodium cellulose may be included in an amount of 0.1 to 10 parts by weight based on 100 parts by weight of the total amount of the soap composition; Sodium chloride may be included in an amount of 0.1 to 5 parts by weight based on 100 parts by weight of the total amount of the soap composition.
상기와 같은 본 발명의 비누 조성물은 통상의 제조방법을 통해 시판될 수 있는 비누 제품으로 제조될 수 있다.The soap composition of the present invention as described above can be produced as a soap product that can be commercially available through conventional manufacturing methods.
자세하게는, a) 비누칩, 기포제, 보습제, 염화나트륨, 색소, 향료, 표백제, 방부제, 항산화제, 변색방지제 및 정제수로 이루어진 군으로부터 선택된 1종 이상을 포함하는 비누베이스 조성물에 본 발명의 약용식물 추출물(소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 또는 이들의 혼합물)을 배합하여 비누 조성물을 제조하는 단계; b) 상기 비누 조성물을 압출(Plodding), 솝바(Soap bar), 절단(Cutting), 형타(Stamping) 공정을 거치는 단계를 통해 제조될 수 있다.Specifically, a) a herbal base composition comprising at least one selected from the group consisting of a soap chip, a foam, a moisturizer, sodium chloride, a pigment, a flavor, a bleach, an antiseptic, an antioxidant, a discoloration inhibitor and purified water, (Syrup extract, oat extract, bovine extract or a mixture thereof) to prepare a soap composition; and b) subjecting the soap composition to a step of subjecting it to a process such as a plodding, a soap bar, a cutting, and a stamping process.
본 발명의 상기 a) 단계는 비누칩, 소듐코코일이세치네이트, 라우릭산과 적량의 색소 희석액을 넣고 고루 혼합함으로써 색소가 골고루 침적되도록 한 후 소듐라우로일사르코시네이트, 포타슘라우레이트를 넣고 혼합한 다음; 순차적으로 보습제인 시어버터, 아르간 오일, 소듐히아루론산, 글리세린를 넣고 균일하게 혼합한 이후; 순차적으로 소듐셀룰로오스, 약용식물 추출물, 염화나트륨, 향료 순으로 투입하고 완전 혼합되도록 고루 교반하여 비누 조성물을 제조할 수 있다.In the step a) of the present invention, sodium lauryl sarcosinate and potassium laurate are added after soap chips, sodium cocoyl ischinate, lauric acid and an appropriate amount of a dye diluent are added and mixed thoroughly so that the dye is evenly deposited After mixing; Shea butter, argan oil, sodium hyaluronic acid and glycerin, which are moisturizing agents, are added sequentially and uniformly mixed; Sequentially, sodium cellulose, medicinal plant extract, sodium chloride, perfume, and the mixture is thoroughly stirred to prepare a soap composition.
본 발명의 상기 b) 단계는 상기 a) 단계를 통해 제조된 비누 조성물을 비누 제조기 넣어 스크류가 비누 조성물을 밀어 다공판을 빠져나오면 절단기가 입상(Noodle)을 잘게 잘라주는 과정을 3회 이상 반복한 다음, 마지막에서는 강한 진공을 걸어서 비누 내부의 공기를 완전히 빼내어 밀도를 높이고 공극을 줄이는 과정을 거친다. 마지막 단계를 나올 때에는 약 50cm간격으로 긴 바(Bar)형태로 잘라 성형 단계로 넘어간다. 성형단계에서는 바 형태의 비누를 4개의 비누 금형이 하나로 된 성형기로 눌러 성형을 하고, 진공 흡착으로 성형된 비누를 빼내는 공정을 거친다.In step b) of the present invention, the soap composition prepared in step a) is put into a soap maker, and when the screw pushes the soap composition out of the perforated plate, the cutter finely cut the noodle is repeated three or more times Next, at the end, a strong vacuum is applied to completely remove the air inside the soap, thereby increasing the density and reducing the air gap. At the end of the last step, the bar is cut into long bars at intervals of about 50 cm. In the molding step, the bar-shaped soap is pressed by a molding machine consisting of four soap molds, and the soap formed by vacuum adsorption is taken out.
상기와 같은 단계를 통해 제조된 성형된 비누는 얇은 종이로 감싸는 속지 포장 단계와, 다시 속지 포장을 소박스인 카톤(Carton) 포장 단계를 거쳐 비누 제품으로 완성되어 시판될 수 있다.The molded soap manufactured through the above steps may be completed with an inlay wrapping step of wrapping the wrapped soap with a thin paper and a soap product through a carton wrapping step in which the inlay wrapping is a small box.
이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are for further illustrating the present invention, and the scope of the present invention is not limited to these examples.
<< 실시예Example 1> 1>
약용식물 추출물 준비Preparation of medicinal plant extract
<1-1> 소리쟁이 추출물의 제조<1-1> Preparation of Syrup extract
본 발명에 사용한 소리쟁이는 2015년 10월 천안시 성거산에서 직접 취하한 것을 물로 깨끗이 세척하여 사용하였다. 소리쟁이의 잎과 뿌리를 모두 사용하였으며, 이때 소리쟁이 잎은 물로 깨끗하게 세척한 뒤 3-4 mm 크기로 준비하였고 뿌리는 물로 깨끗하게 세척한 뒤 1-2mm의 크기로 잘라 준비한 다음 건조하였다. 건조과정은 채반에 받쳐 3일 내지 일주일간 음건 풍수하거나 또는 식품 건조기를 이용하여 수분 함량이 10%이내까지 되도록 10-14시간 건조시킬 수 있다.The spider used in the present invention was directly washed in October 2015 at Sunggasan in Cheonan and cleaned with water. The leaves and roots of the spikelets were both used. The spikelet leaves were cleaned with water and then prepared 3-4 mm. The roots were cleaned with water and then cut to 1-2 mm and then dried. The drying process can be carried out for 3 to 7 days on shrubs, or dried for 10-14 hours using a food drier until the moisture content is within 10%.
상기와 같은 과정을 통해 준비한 소리쟁이 1kg에 물 5kg을 첨가하여 1시간 동안 수침하는 과정을 통해 물이 소리쟁이에 완전히 침지되도록 한 후 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물 5kg을 첨가하여 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득하였다. 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 여과한 뒤 농축 및 동결건조 과정을 거쳐 최종적으로 본 발명의 소리쟁이 추출물을 파우더 형태로 제조하였다.5 kg of water was added to 1 kg of syrup prepared by the above procedure, and water was soaked in the syringe for 1 hour. After the water was completely immersed in the syringe, it was withdrawn at 50-60 ° C for 7-8 hours, / 3, the extract was firstly obtained except for the gherkin, and 5 kg of water was added again to the gherkin and the mixture was cut at 50-60 ° C for 7 to 8 hours. When the volume of the solution reached 1/3 of the initial amount of the solution, Secondary extracts were obtained. The primary extract and the secondary extract thus obtained were combined, filtered, concentrated and lyophilized, and finally, the powdery extract of the present invention was prepared in powder form.
<1-2> 오이풀 추출물의 제조≪ 1-2 >
본 발명에 사용한 오이풀은 2015년 11월에 천안시 광덕산에서 직접 취하한 것을 물로 깨끗이 세척하여 사용하였다. 세척된 오이풀 뿌리 부분을 건조한 뒤, 이후 상기 실시예 <1-1>과 동일한 방식으로 오이풀 추출물을 제조하였다.The ointment used in the present invention was directly removed from Gwangdeok Mountain in Cheonan City in November 2015 and cleaned with water. The washed oat root was dried, and then the oat extract was prepared in the same manner as in Example <1-1>.
<1-3> 조릿대 추출물의 제조<1-3> Preparation of Sasa extract
본 발명에 사용한 조릿대는 2015년 11월에 천안시 광덕산에서 직접 취하한 것을 물로 깨끗이 세척하여 사용하였다. 세척된 조릿대 잎 부분을 건조한 뒤, 이후 상기 실시예 <1-1>과 동일한 방식으로 조릿대 추출물을 제조하였다.The sludge used in the present invention was directly removed from Kwangdeok Mountain in Cheonan City in November 2015 and cleaned with water. After the washed sage leaves were dried, Sasa extract was prepared in the same manner as in Example <1-1>.
이렇게 수득한 각각의 추출물은 4℃에서 냉장보관하면서 하기 실험의 시료로 사용하였다. Each of the extracts thus obtained was used as a sample for the following experiment while being stored at 4 ° C in a refrigerator.
<< 실시예Example 2> 2>
약용식물 추출물의 항염 효과Anti-inflammatory effect of medicinal plant extracts
<2-1> 산화질소 생성 억제 활성<2-1> Nitric oxide formation inhibitory activity
상기 실시예 1을 통해 제조된 본 발명의 약용식물 추출물의 항염증 효과를 확인하기 위하여, 산화질소(NO) 생산 억제 활성을 측정하였다.In order to confirm the anti-inflammatory effect of the medicinal plant extract of the present invention prepared in Example 1, the inhibitory activity of NO production was measured.
산화질소(NO)는 중요한 세포 내 전염증 매개인자로서, 수퍼옥사이드라디칼과 반응하여 과산화아질산 이온(peroxynitrite anion, ONOO-)을 생산하며, 이렇게 생산된 과산화아질산 이온은 염증 활성을 유도하고 관절염, 궤양성대장염, 전신홍반루푸스과 같은 다양한 병리학적 조건을 야기하는 것으로 알려져 있다. 따라서 산화질소(NO) 생산 억제 기작을 통하여 염증 반응을 억제할 수 있다.Nitric oxide (NO) is an important intracellular proinflammatory mediator, which reacts with a superoxide radical to produce peroxynitrite anion (ONOO-). The nitrite peroxide thus produced induces inflammatory activity and causes arthritis, ulcers It is known to cause a variety of pathological conditions such as chronic colitis and systemic lupus erythematosus. Therefore, the inflammatory reaction can be inhibited by a mechanism of inhibiting nitric oxide (NO) production.
본 실험에서는 마우스 대식세포(RAW264.7 세포)에 본 발명의 추출물을 각각 전처리한 후, LPS를 처리하여 아질산염(산화질소의 지표) 수준을 측정하였으며, 이때 아질산염은 배지 내에서 그리스시약을 기초로 한 colorimetric assay를 이용하여 측정하였다. 산화질소(NO)의 기질인 L-arginine은 L-citrulline과 일산화질소로 변하는데, 이는 빠르게 안정된 이산화질소, 아질산염, 질산염으로 변한다. 그리스 시약은 아질산염과 화학 반응하여 보라색의 아조염을 형성하고 이것은 일산화질소의 농도와 일치하기 때문에, 아조염의 농도로부터 아질산염의 농도를 측정하여 540 nm에서 그 최대 흡수정도를 측정하여 구할 수 있다.In this experiment, the extract of the present invention was pretreated with mouse macrophages (RAW264.7 cells), and the level of nitrite (indicator of nitric oxide) was measured by treating LPS with nitric acid, Were measured using a colorimetric assay. L-arginine, a substrate for nitric oxide (NO), turns into L-citrulline and nitrogen monoxide, which quickly turns into stable nitrogen dioxide, nitrite, and nitrate. The Greek reagent chemically reacts with nitrite to form a purple azo salt, which is consistent with the concentration of nitrogen monoxide, and can be determined by measuring the nitrite concentration from the concentration of the azo salt and measuring its maximum absorption at 540 nm.
자세하게는 마우스 대식세포(RAW264.7 세포)를 96 웰 플레이트에 5.0×105 cells/well로 분주하여 배양한 다음, 본 발명의 약용식물 추출물로서 소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 단독과 이들의 혼합물(1:1:1의 중량비)을 100 μg/ml 농도로 처리한 후, 1μg/ml 농도의 LPS를 처리하여 37℃, 5% CO2 인큐베이터에서 24시간 배양하고, 산화질소(NO) 양은 그리스시약으로 측정하였다. 즉, 세포배양액 100μl와 6mg/ml 농도의 그리스 시약 100μl을 혼합하여 반응시킨 후, 아질산염(NO2-)을 540 nm에서 ELISA microplate reader (Tecan, USA)로 흡광도를 측정하였다. Sodium nitrite (NaNO2)로 흡광도를 측정하여 표준곡선을 얻은 후, NO의 농도를 산출하였다.In detail, mouse macrophages (RAW 264.7 cells) were divided into 96-well plates at a density of 5.0 × 10 5 cells / well and cultured. Then, as a medicinal plant extract of the present invention, Sophorae extract, Osiris extract, (1: 1: 1) was treated at a concentration of 100 μg / ml, treated with 1 μg / ml of LPS and incubated in a 5% CO 2 incubator at 37 ° C. for 24 hours. Was measured with a grease reagent. In other words, absorbance of nitrite (NO2-) was measured at 540 nm with an ELISA microplate reader (Tecan, USA) after 100 μl of cell culture solution and 100 μl of 6 mg / ml grease reagent were mixed and reacted. Absorbance was measured with sodium nitrite (NaNO 2 ) to obtain a standard curve, and the concentration of NO was calculated.
그 결과 도 1에서 나타낸 바와 같이, 대식세포에 LPS만을 처리한 실험군(아질산염 함량이 6.5배 증대)과 비교하여 본 발명의 약용식물 추출물을 처리한 실험군에서 아질산염 수준이 감소되는 것을 알 수 있었으며, 특히 본 발명의 약용식물 추출물 3종의 혼합물을 처리한 실험군에서 25.7% 까지 아질산염 수준이 감소되는 것을 확인할 수 있었다. 참고로 도 1에서 Cont는 LPS 및 약용식물 추출물을 처리하지 않은 무처리군이며, 100은 본 발명의 약용식물 추출물을 100μg/ml로 처리한 후 LPS를 처리하지 않은 실험군을 의미한다.As a result, as shown in Fig. 1, it was found that the nitrite level was reduced in the experimental group treated with the medicinal plant extract of the present invention compared with the experimental group (the nitrite content was increased 6.5 times) treated with LPS only in the macrophages, It was confirmed that the nitrite level was reduced to 25.7% in the experimental group treated with the mixture of the three medicinal plant extracts of the present invention. For reference, in FIG. 1, Cont represents the untreated group treated with LPS and the medicinal plant extract, and 100 indicates the experimental group treated with 100 μg / ml of the medicinal plant extract of the present invention and not treated with LPS.
상기와 같은 결과를 통해 본 발명의 약용식물 추출물이 산화질소 생성을 효과적으로 억제할 수 있음을 확인하였으며, 특히 추출물 3종의 혼합물의 경우 단독의 추출물 대비 항염 효과가 더욱 우수함을 확인할 수 있었다.From the above results, it was confirmed that the medicinal plant extract of the present invention can effectively inhibit the production of nitrogen oxides. In particular, it was confirmed that the mixture of three kinds of extracts is superior to the extract alone.
<2-2> <2-2> 카라기난Carrageenan 족 부종( Pediatric edema CarrageenanCarrageenan Foot Edema)에서 항염증 효과 측정 Foot Edema)
본 발명의 약용식물 추출물로서 소리쟁이 추출물, 오이풀 추출물, 조릿대 추출물 단독과 이들의 혼합물을 100mg/kg씩 쥐의 복강으로 투여하고 1시간 후, 0.1% 카라기난 용액 0.5 ㎖을 실험 동물의 뒷 발바닥에 주입하여 염증을 유발했다. 카라기난 주입 직후와 주입 후 4시간 뒤의 쥐의 발부피의 변화를 측정하고, 그 결과를 하기 표 1에 기재하였다.As a medicinal plant extract of the present invention, 100 mg / kg of Sophora rhamnospora extract, oat extract, and Sasa extract alone and a mixture thereof were administered to the abdominal cavity of rats. After 1 hour, 0.5 ml of a 0.1% carrageenan solution was injected into the back soles of the experimental animals To induce inflammation. Changes in the amount of paw blood immediately after injection of carrageenan and 4 hours after injection were measured, and the results are shown in Table 1 below.
%억제율 = (1 - ΔV처리군 / ΔV대조군)×100% Inhibition rate = (1 -? V treated group /? V control group) x 100
(ΔV : 발 부피의 변화)(? V: change in foot volume)
상기와 같은 결과를 통해 본 발명의 약용식물 추출물이 염증으로 유발된 부종을 억제할 수 있음을 확인하였으며, 특히 추출물 3종의 혼합물의 경우 단독의 추출물 대비 항염 효과가 우수함을 확인할 수 있었다.From the above results, it was confirmed that the medicinal plant extract of the present invention can suppress edema induced by inflammation. In particular, it was confirmed that the mixture of three kinds of extracts is superior in the anti-inflammatory effect compared to the single extract.
<< 실시예Example 3> 3>
비누 조성물 제조Soap composition manufacturing
하기 표 2의 구성비를 가진 비누 조성물 제조하였다.A soap composition having the composition ratios shown in Table 2 was prepared.
먼저, 비누칩, 소듐코코일이세치네이트, 라우릭산과 적량의 색소 희석액을 넣고 고루 혼합함으로써 색소가 골고루 침적되도록 한 후 소듐라우로일사르코시네이트, 포타슘라우레이트를 넣고 혼합하였다. 그 이후 순차적으로 보습제인 시어버터, 아르간 오일, 소듐히아루론산, 글리세린를 넣고 균일하게 혼합하였다. 완전히 혼합된 이후에는 순차적으로 소듐셀룰로오스, 약용식물 추출물, 염화나트륨, 향료 순으로 투입하고 완전 혼합되도록 고루 교반하여 비누 조성물을 제조하였다. 참고로, 색소는 보락에서 구입한 Orange No.2(CI 15510)를 0.1% 농도로 희석하여 3%를 사용하였으며(;함량 0.003 %), 향료로는 한불화농에서 구입한 상품 Lola를 1.2%의 함량으로 사용하였다.First, soap chips, sodium cocoyl succinate, lauric acid and an appropriate amount of a coloring matter diluent were added, and the mixture was thoroughly mixed to uniformly deposit the coloring matter. Then sodium lauroyl sarcosinate and potassium laurate were added and mixed. After that, shea butter, argan oil, sodium hyaluronic acid and glycerin, which are moisturizing agents, were added sequentially and mixed uniformly. After thorough mixing, sodium cellulose, medicinal plant extract, sodium chloride and flavoring were sequentially added in order, and the mixture was thoroughly stirred to prepare a soap composition. For reference, the coloring matter was prepared by diluting Orange No. 2 (CI 15510) purchased from Borak with 0.1% concentration and using 3% (content: 0.003%), Respectively.
이후 비누 제조 기계에서 압출(Plodding), 솝바(Soap bar), 절단(Cutting), 형타(Stamping)과정을 거침으로써 최종적인 고형 비누를 제조하였다.Then, the final solid soap was produced by subjecting the soap making machine to the processes of plodding, soap bar, cutting, and stamping.
<< 실시예Example 4> 4>
비누 조성물의 작업성 평가Evaluation of workability of soap composition
본 발명의 비누 조성물에 포함되는 약용식물 추출물의 첨가 비율에 따른 작업성을 평가하였다. 이를 위해, 비누 제조 과정에서 비누가 기계에 달라붙고 끈적거리는 이형성 상태를 5단계, 즉 매우 우수, 우수, 보통, 불량, 매우 불량으로 구분하여 평가하였다.The workability was evaluated according to the addition ratio of the medicinal plant extract contained in the soap composition of the present invention. For this purpose, the soap was adhered to the machine during the soap manufacturing process and the sticky dentifrice was classified into five stages: very good, excellent, normal, poor, and very poor.
(단위: 중량%)Horseradish extract
(Unit: wt%)
(단위: 중량%)Oat extract
(Unit: wt%)
(단위: 중량%)Sasa extract
(Unit: wt%)
상기 표 3에서 나타낸 바와 같이, 비누 조성물에 포함되는 약용식물 추출물의 첨가비율이 15% 미만에서는 작업성이 좋은 것으로 보이나, 그 이상이 될 때에는 비누 조성물의 작업성이 떨어지는 것을 확인할 수 있었다.As shown in Table 3, when the addition ratio of the medicinal plant extract contained in the soap composition is less than 15%, the workability is good, but when it is more than 15%, the workability of the soap composition is inferior.
<< 실시예Example 5> 5>
약용식물 추출물의 단독 첨가에 따른 여드름 유발균의 항균력 측정Antimicrobial activity of acne induced bacteria by addition of medicinal plant extracts
본 실험에서는 상기 실시예 1을 통해 제조된 본 발명의 약용식물 추출물을 각각 첨가하여 제조되는 비누 조성물의 경우 실제 여드름 유발균에 대한 항균성을 나타내는지를 조사하였다.In this experiment, the anti-microbial properties of the soap composition prepared by adding the medicinal plant extract of the present invention prepared in Example 1 to actual acne-causing bacteria were investigated.
여드름의 원인균으로 알려진 프로피오니박테리움 아크네스(P. acnes)에 대한 항균효과를 구하였다. 액체배지 희석법에 의한 프로피오니박테리움 아크네스(P. acnes)에 대한 최소 성장억제농도(Minimun Inhibitory Concentration, MIC)를 구하였다.The antimicrobial effect of P. acnes , which is known as a cause of acne, was determined. The minimum inhibitory concentration (MIC) for P. acnes was determined by liquid culture dilution method.
하기 표 4의 조성비를 이용하여 상기 실시예 3의 방법과 유사하게 제조된 본 발명의 비누 조성물을 멸균 증류수로 100배 희석하고, 5ml의 액체 배지에 28 까지 2배수 단계 희석한 후 시료로 사용하였다. 프로피오니박테리움 아크네스(P. acnes)를 5% sheep blood를 첨가한 TS(trypticase soy) broth를 사용하여 35℃에서 48시간 동한 혐기 조건으로 배양한 후 시험에 사용하였다. 각각의 접종 균은 2×106 CFU/well이 되도록 조절하여 시료와 함께 24시간 동안 배양한 후, 육안 및 현미경으로 균의 성장을 관찰하였고, 흡수파장 540nm에서 흡광도를 측정하여 순수배양액의 흡광도 값과 같은 결과를 얻은 것을 최소억제농도로 결정하였다. 그 결과를 하기 표 5에 나타내었다.Using the composition ratios in Table 4 below, the inventive soap compositions prepared in analogy to the method of Example 3 were diluted 100-fold with sterile distilled water, diluted 2-fold to 28 in 5 ml of liquid medium and used as samples . Propionibacterium acnes ( P. acnes ) was cultured in TS (trypticase strain) broth supplemented with 5% sheep blood at 35 ° C for 48 hours in anaerobic condition and then used for the test. Each inoculum was adjusted to 2 × 10 6 CFU / well and incubated with the sample for 24 hours. The growth of the bacteria was observed with the naked eye and a microscope. The absorbance at 540 nm was measured and the absorbance Was determined as the minimum inhibitory concentration. The results are shown in Table 5 below.
그 결과 상기 표 5에서 나타낸 바와 같이, 약용식물 추출물을 포함하지 않은 비누 조성물(비교예) 대비 약용식물 추출물을 포함하는 비누 조성물(실시예 1-9)의 경우 여드름 유발균인 프로피오니박테리움 아크네스(P. acnes)에 대한 항균 활성이 우수한 것을 확인할 수 있었다.As a result, as shown in Table 5, in the case of the soap composition containing the medicinal plant extract (Examples 1-9) in comparison with the soap composition not containing the medicinal plant extract (comparative example), in the case of the propionibacterium arc It was confirmed that the antimicrobial activity against P. acnes was excellent.
<< 실시예Example 6> 6>
약용식물 추출물의 단독 첨가에 따른 호기성 Aerobic by addition of medicinal plant extract alone 피부상재균의Skin 항균력 측정 Antimicrobial activity measurement
본 실험에서는 상기 실시예 1을 통해 제조된 본 발명의 약용식물 추출물을 각각 첨가하여 제조되는 비누 조성물의 경우 실제 호기성 피부상재균에 대한 항균성을 나타내는지를 조사하였다.In this experiment, the soap compositions prepared by adding the medicinal plant extract of the present invention prepared in Example 1 were examined for the antimicrobial activity against the aerobic skin microbes.
대표적인 피부 상재균인 황색포도상구균(Staphylococcus aureus), 표피포도구균(Staphylococcus epidermidis) 및 화농성 연쇄상구균(Sreptococcus pyogenes)은 Muller-Hiton broth를 이용하여 37℃에서 18시간 동한 배양 후 사용하였고, 화농성 연쇄상구균(S. pyogenes)의 경우는 CO2 배양기에서 배양하였다. 각각의 접종 균은 2×106 CFU/well이 되도록 조절하여 희석된 비누 조성물 시료(상기 표 3의 조성비를 이용하여 상기 실시예 2의 방법과 유사하게 제조된 본 발명의 비누 조성물을 멸균 증류수로 100배 희석하고, 5ml의 액체 배지에 28 까지 2배수 단계 희석한 후 시료로 사용함)와 함께 18시간 동안 배양한 후, 육안 및 현미경으로 균의 성장을 관찰하였고, 흡수파장 540nm에서 흡광도를 측정하여 순수 배양액의 흡광도 값과 같은 결과를 얻은 것을 최소억제농도로 결정하였다. 그 결과를 하기 표 5에 나타내었다. Staphylococcus aureus , Staphylococcus epidermidis , and Sreptococcus spp. pyogenes ) were cultured for 18 hr at 37 ° C using Muller-Hiton broth and cultured in CO 2 incubator for S. pyogenes . Each inoculum was adjusted to be 2 x 10 6 CFU / well to prepare a diluted soap composition sample (the composition of the present invention prepared similarly to the method of Example 2 above using the composition ratio shown in Table 3) 100-fold dilution, diluted 2-fold to 28 in 5 ml of a liquid medium, and used as a sample) for 18 hours. The growth of the microorganism was observed with the naked eye and a microscope, and the absorbance was measured at an absorption wavelength of 540 nm The minimum inhibitory concentration was determined to be the same as the absorbance value of the pure culture medium. The results are shown in Table 5 below.
그 결과 상기 표 6에서 나타낸 바와 같이, 약용식물 추출물을 3중량% 또는 5중량%로 포함하는 비누 조성물에서만 황색포도상구균(Staphylococcus aureus) 및 표피포도구균(Staphylococcus epidermidis)에 대한 항균활성이 나타났으며, 그 외의 실시예에서는 항균활성을 보이지 않았다. 또한, 화농성 연쇄상구균(Sreptococcus pyogenes)에 대한 항균활성은 모든 실험군에서 보이지 않는 것을 확인할 수 있었다.As a result, as shown in Table 6, antimicrobial activity against Staphylococcus aureus and Staphylococcus epidermidis was observed only in a soap composition containing 3% by weight or 5% by weight of a medicinal plant extract , But did not show antimicrobial activity in other Examples. In addition, it was confirmed that the antimicrobial activity against purulent streptococci ( Sreptococcus pyogenes ) was not observed in all experimental groups.
<< 실시예Example 7> 7>
약용식물 추출물의 혼합 첨가에 따른 여드름 유발균의 항균력 측정Measurement of Antimicrobial Activity of Acne Inducing Bacteria by Addition of Medicinal Plant Extract
본 실험에서는 상기 실시예 1을 통해 제조된 본 발명의 약용식물 추출물을 혼합 첨가하여 제조되는 비누 조성물의 경우 여드름 유발균에 대한 항균성이 증대되는지 여부를 조사하였다.In this experiment, the antibacterial properties of the soap composition prepared by mixing the medicinal plant extract of the present invention prepared in Example 1 with respect to acne-causing bacteria were examined.
하기 표 7의 조성비를 이용하여 제조된 본 발명의 비누 조성물을 이용하여 상기 실시예 4와 동일한 방법으로 여드름 유발균에 대한 항균성을 평가하였다.Antimicrobial activity against acne-causing bacteria was evaluated in the same manner as in Example 4 using the composition of the present invention prepared using the composition ratios shown in Table 7 below.
그 결과 상기 표 8에서 나타낸 바와 같이, 본 발명의 약용식물 추출물 3종을 혼합한 실시예 13-18에서 여드름 유발균인 프로피오니박테리움 아크네스(P. acnes)에 대한 항균 활성이 우수한 것을 확인할 수 있었으며, 그 중에서도 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물이 1 : 2 : 2의 중량비로 포함된 비누 조성물에서 여드름 유발균에 대한 탁월한 항균효과를 보여주었다.As a result, as shown in Table 8, it was confirmed that the antibacterial activity against Propionibacterium acnes ( P. acnes ), an acne-causing microorganism, was excellent in Examples 13-18 in which three kinds of medicinal plant extracts of the present invention were mixed And showed excellent antimicrobial effect against acne-inducing bacteria in a soap composition containing a mixture of 1: 2: 2 by weight of the extracts of Cryptomeria japonica, Osiris extract and Sasa extract.
<< 실시예Example 8> 8>
약용식물 추출물의 혼합 첨가에 따른 호기성 Aerobic activity of mixed medicinal plant extracts 피부상재균의Skin 항균력 측정 Antimicrobial activity measurement
본 실험에서는 상기 실시예 1을 통해 제조된 본 발명의 약용식물 추출물을 혼합 첨가하여 제조되는 비누 조성물의 경우 호기성 피부상재균에 대한 항균성이 증대되는지 여부를 조사하였다.In this experiment, the inventors of the present invention investigated whether the antimicrobial activity of the soap composition prepared by mixing the medicinal plant extract of the present invention prepared in Example 1 with the aerobic skin microbes was increased.
상기 표 7의 조성비를 이용하여 제조된 본 발명의 비누 조성물을 이용하여 상기 실시예 5와 동일한 방법으로 호기성 피부상재균에 대한 항균성을 평가하였다.The antimicrobial activity of the aerobic skin microflora was evaluated in the same manner as in Example 5 using the soap composition of the present invention prepared using the composition ratios shown in Table 7 above.
그 결과 상기 표 9에서 나타낸 바와 같이, 본 발명의 약용식물 추출물 3종을 혼합한 실시예 13-18에서 황색포도상구균(Staphylococcus aureus) 및 표피포도구균(Staphylococcus epidermidis)에 대한 항균활성을 보여주었으며, 화농성 연쇄상구균(Sreptococcus pyogenes)에 대한 항균활성은 실시예 16-18에서 나타났으며, 특히 실시예 16에서 두드러지게 우수한 항균활성(실시예 17 및 18과 비교하여 화농성 연쇄상구균(Sreptococcus pyogenes)에 대한 2-3배 높은 항균 활성을 보임)을 보여주었다. As a result, as shown in Table 9, antibacterial activity against Staphylococcus aureus and Staphylococcus epidermidis was shown in Examples 13-18 in which three kinds of medicinal plant extracts of the present invention were mixed, Purulent Streptococcus ( Sreptococcus The antimicrobial activity against pyogenes was shown in Examples 16-18, and particularly excellent antimicrobial activity in Example 16 (2-3 times higher for Sreptococcus pyogenes compared to Examples 17 and 18) Showing antimicrobial activity).
<< 실시예Example 9> 9>
본 발명의 비누 조성물의 피부 자극도 실험The skin irritation degree of the soap composition of the present invention
자극성 시험용 반창고를 이용하여 본 발명의 약용식물 추출물을 포함하는 비누 조성물(실시예 10-18)의 5% 수용액을 반창고의 거즈 부분에 1ml 흡수시킨 후 사람의 팔 윗부분에서 붙인다. 붙인 후 48시간이 경과하여 반창고를 제거하고 1시간 후 피부를 관찰하였다. 평가방법은 아래 평가표에 의해 평가하였다. 1 ml of a 5% aqueous solution of a soap composition (Examples 10-18) containing the medicinal plant extract of the present invention was absorbed into the gauze portion of the bandage using a stimulant test band-aid, and then stuck on the upper part of the human arm. After 48 hours, the bandage was removed and the skin was observed 1 hour later. The evaluation method was evaluated by the following evaluation table.
판정은 각 실시예별 10명(총 100명)을 대상으로 실험하여 그 결과를 하기 표 11에 나타내었다.The results are shown in Table 11 below. The results are shown in Table 11 below.
상기 표 11에서 나타낸 바와 같이, 본 발명의 비누 조성물의 경우 피부자극도가 거의 없는 것으로 나타나, 사용시 피부에 안정한 것을 확인할 수 있었다.As shown in Table 11, the soap composition of the present invention showed almost no skin irritation, indicating that it was stable to the skin during use.
<< 실시예Example 10> 10>
본 발명의 비누 조성물의 The soap composition of the present invention 보습력Moisture power , 상처 치유 효과, 가려움증 완화 효과, 피부강화 및 아토피 피부 증산 완화 효과 실험, Wound healing effect, mitigating effect of itching, skin strengthening, and effect of alleviation of atopic skin hyperplasia
본 발명의 약용식물 추출물을 포함하는 비누 조성물(실시예 10-18)의 보습력, 상처 치유 효과, 가려움증 증상 완화 효과, 피부강화, 아토피 피부 증상 완화에 대하여 50 여명의 아토피 피부염을 가진 환자를 5명씩 나누어 10군으로 하여 아침, 저녁 두 번에 걸쳐서 아토피 피부염 증상을 보이는 부위에 사용하게 하여 효과를 평가하였다.In the case of the soap composition (Examples 10-18) containing the medicinal plant extract of the present invention, at least five patients with atopic dermatitis of at least about 50 in respect of moisturizing power, wound healing effect, mitigating effect of itching, skin strengthening, And divided into 10 groups. The effect was evaluated in the morning and in the evening by using it in areas showing atopic dermatitis symptoms twice.
이때 평가는 매우우수 10점, 우수 8점, 보통 6점, 나쁨 4점, 매우나쁨 2점의 기준에 따라 평가하였고 이에 따른 결과를 표 12에 나타냈다.At this time, the evaluation was performed according to the criterion of excellent 10 points, excellent 8 points, average 6 points, poor 4 points, and very poor 2 points, and the results are shown in Table 12.
상기 표 12에서 나타낸 바와 같이, 본 발명의 비누 조성물의 경우 비교예와 대비하여 보습력, 상처 치유 효과, 가려움증 완화 효과, 피부강화 및 아토피 피부 증상 완화 효과가 증대되는 것을 확인할 수 있었으며, 특히, 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물 3종을 혼합하여 제조한 비누 조성물의 경우 더욱 두드러지게 가려움증 완화 효과 및 아토피 피부 증상 완화 효과를 보임을 확인할 수 있었다.As shown in Table 12, it was confirmed that the soap composition of the present invention is improved in moisturizing power, wound healing effect, itching relief effect, skin strengthening effect and atopic skin symptom relief effect in comparison with the comparative example, It was confirmed that the soap composition prepared by mixing three kinds of extracts, oat extract and Sasa extract showed remarkably more itching relieving effect and atopic skin symptom relief effect.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to the preferred embodiments. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than by the foregoing description, and all differences within the scope of equivalents thereof should be construed as being included in the present invention.
Claims (10)
상기 소리쟁이 추출물, 오이풀 추출물 및 조릿대 추출물은 전체 비누 조성물 100중량부를 기준으로 1 내지 10중량부로 포함되는 것을 특징으로 하는 비누 조성물.The method according to claim 1,
Wherein the composition comprises 1 to 10 parts by weight based on 100 parts by weight of the total composition of the soap composition.
상기 조성물은 비누칩, 기포제, 천연지방산, 보습제, 나트륨셀룰로오스, 염화나트륨, 색소, 향료, 계면활성제, 표백제, 방부제, 항산화제, 변색방지제 및 정제수로 이루어진 군으로부터 선택된 1종 이상을 더 포함하는 것을 특징으로 하는 비누 조성물.The method according to claim 1,
The composition further comprises at least one member selected from the group consisting of a soap chip, a foaming agent, a natural fatty acid, a moisturizing agent, sodium cellulose, sodium chloride, a pigment, a flavoring agent, a surfactant, a bleaching agent, an antiseptic agent, ≪ / RTI >
상기 조성물은 액상, 크림상, 페이스트상 또는 고체상의 제형을 가지는 것을 특징으로 하는 비누 조성물.The method according to claim 1,
Wherein the composition has a formulation in a liquid, cream, paste or solid form.
상기 조성물은 항염 활성 및 항균 활성을 가지며,
상기 항균 활성은 여드름 유발균인 프로피오니박테리움 아크네스(P. acnes)에 대한 항균 활성과 더불어, 호기성 피부상재균으로 황색포도상구균(Staphylococcus aureus), 표피포도구균(Staphylococcus epidermidis) 및 화농성 연쇄상구균(Sreptococcus pyogenes) 모두에 대한 항균 활성을 갖는 것을 특징으로 하는 비누 조성물.The method according to any one of claims 1, 4, 5, and 6,
The composition has anti-inflammatory activity and antimicrobial activity,
The antimicrobial activity is antimicrobial activity against P. acnes , which is an acne-causing microorganism, as well as aerobic strains of Staphylococcus aureus , Staphylococcus epidermidis , Lt; RTI ID = 0.0 > ( Sreptococcus pyogenes ). ≪ / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160056380A KR101790250B1 (en) | 2016-05-09 | 2016-05-09 | Soap composition comprising of medicinal plants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160056380A KR101790250B1 (en) | 2016-05-09 | 2016-05-09 | Soap composition comprising of medicinal plants |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101790250B1 true KR101790250B1 (en) | 2017-11-20 |
Family
ID=60809223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160056380A KR101790250B1 (en) | 2016-05-09 | 2016-05-09 | Soap composition comprising of medicinal plants |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101790250B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200082813A (en) * | 2018-12-31 | 2020-07-08 | 대봉엘에스 주식회사 | Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007204423A (en) * | 2006-02-01 | 2007-08-16 | Toyo Ink Mfg Co Ltd | Method for producing extract of bamboo grass and use of the extract |
-
2016
- 2016-05-09 KR KR1020160056380A patent/KR101790250B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007204423A (en) * | 2006-02-01 | 2007-08-16 | Toyo Ink Mfg Co Ltd | Method for producing extract of bamboo grass and use of the extract |
Non-Patent Citations (2)
Title |
---|
박주아 외, "소리쟁이(Rumex crispus L.) 뿌리 추출물의 피부상재균에 대한 항균활성과 항염증 효과", 대한피부미용학회지 제9권 제2호, pp.9-16 (2011.05.)* |
장영아 외, "오이풀 뿌리 분획물의 화장품 소재로서의 약리활성 연구", 大韓本草學會誌 제27권 제2호, pp.43-46 (2012.03.)* |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200082813A (en) * | 2018-12-31 | 2020-07-08 | 대봉엘에스 주식회사 | Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea |
KR102150927B1 (en) | 2018-12-31 | 2020-09-02 | 대봉엘에스 주식회사 | Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101870780B1 (en) | A feminine cleanser composition comprising roes damascena flower oil and propolis complex extracts | |
KR101253374B1 (en) | Cosmetic composition for controlling anti-acne and anti-comedo | |
CN112048402A (en) | Antibacterial, stain-removing and peculiar smell-removing underwear soap and preparation method thereof | |
KR102400179B1 (en) | Cosmetic composition antimicroboal, antioxidation, whitening or anti-inflammation comprising artemisia capillaris thunberg and olive extract | |
KR101862646B1 (en) | A moisturizing soap composition comprising of medicinal plants | |
KR101332215B1 (en) | Cosmetic composition containing fermentated complex of extracts with cryptomeria japonica and nelumbo nucifera for acne improvement and enhancing immune system | |
KR101812675B1 (en) | Composite of Natural soap and Method of manufacturing thereof | |
KR101274811B1 (en) | Potent anti-acne composition containing perilla frutescens and/or lygodium japonicum extract | |
KR101790250B1 (en) | Soap composition comprising of medicinal plants | |
KR100564225B1 (en) | Athlete's foot, eczema prevention and treatment composition containing sagan, cheongpi, fat milk, casualty, Schisandra chinensis extract | |
KR102539209B1 (en) | Cosmetic composition for skin-whitening, anti-oxidant, anti-inflammatory, skin anti-irritation and moisturizing comprising the extract of Nymphaea alba, Backhousia citriodora and Malus pumila | |
JP2000191513A (en) | Skin washing agent containing agaricus mushroom extract solution | |
KR102561258B1 (en) | Composition for controlling sebum and improving pore comprising Jasminum Officinale, Salix Alba (willow) bark and Solanum melogena fruit extract | |
KR101869763B1 (en) | Composition for preventing and curing dermatophytosis | |
KR101924822B1 (en) | A feminine cleanser composition comprising lentil bean extract | |
KR101930409B1 (en) | Detergen composition for prevention of hair loss comprising iceplant as active ingredient | |
KR100645988B1 (en) | Antimicrobial body cleanser composition comprising herbal extracts | |
KR102059620B1 (en) | Cosmetic composition for allevation of acne with the extract of Lycopus lucidus or its fraction | |
KR100754748B1 (en) | Compositiion for Inhibiting 5?-Reductase Activity and Cosmetic Composition for Inhibiting Secretion of Sebum containing Extract of Ulmus davidiana as Active Ingredient | |
KR20030027482A (en) | Cosmetic Compositions Comprising Manuka Honey as Active Ingredient for Skin Caring | |
KR20210020817A (en) | Antimicrobial composition against acne-inducing bacteria comprising extract of Garcinia mangostana L., and formulation for preventing or treating acne comprising the same | |
KR101829897B1 (en) | A feminine cleanser composition comprising roes damascena flower oil | |
KR102292487B1 (en) | Composition for feminine hygiene care containing Copaiba resin extract | |
KR20210043098A (en) | Cosmetic composition for regulating microbe in skin comprising extract of rosa multiflora thunberg fruit or fractions from thereof | |
KR102643752B1 (en) | Cosmetic composition for controlling sebum and improving pore comprising fermentation product of primula veris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |